“Jail inmates who continue to receive methadone treatment for opioid use disorder have better outcomes both during and after incarceration, according to a new Yale study conducted in conjunction with several state agencies.
People receiving methadone treatment are often forced to withdraw from treatment when they go to jail, which can induce severe withdrawal symptoms and hamper their abilities to successfully reenter society after incarceration. To evaluate the impacts of forced withdrawal, the researchers investigated the effects of providing methadone in the New Haven Correctional Center. Published on Jan. 16 in the Journal of Addiction Medicine, the study was conducted in partnership with the APT Foundation and the Connecticut Department of Mental Health and Addiction Services.
“What this study has shown, from a policy perspective, is that if you maintain people on an evidence-based, FDA-approved medication for the disease of substance use disorder, then you can improve people’s lives when they leave [prison],” said Kathleen Maurer, director of Health and Addiction Services for Connecticut’s correctional system, who led the methadone program.”
Source: YaleDailyNews.com – February 2, 2018